| Financial Year |
March 31 2023 |
| Monetary Funds |
418,164,300.26 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
285,638,876.85 |
| Accounts Receivable |
748,564,281.52 |
| Advances to Suppliers |
19,896,541.14 |
| Other Receivables |
3,023,429.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
610,672,351.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
88,760,179.35 |
| Total Current Assets |
2,520,236,652.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
18,796,336.08 |
| Fixed Assetes |
1,132,792,186.87 |
| Under-construction Projects |
973,439,722.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
218,654,739.63 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
12,112,946.00 |
| Other Non-Current Assets |
108,189,882.47 |
| Sub-Total of Non-Current Assets |
2,646,547,466.90 |
| Total Assets |
5,166,784,119.61 |
| Short-Term Loans |
385,205,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
167,780,441.21 |
| Accounts Received In Advance |
79,446.41 |
| Employee Compensation Payable |
847,790.68 |
| Taxes Payable |
17,552,756.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
212,241.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
25,418,866.26 |
| Sub-Total of Current Liabilities |
604,837,392.50 |
| Long-term Loans |
725,989,012.20 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
61,011,928.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
855,927,495.31 |
| Total Liabilities |
1,460,764,887.81 |
| Paid-In Capital(Or Share Stock) |
261,753,484.00 |
| Capital Surplus |
1,153,492,167.64 |
| Surplus Reserve |
163,350,749.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,120,387,519.87 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,706,019,231.80 |
| Owner's Equity（Stockholder's Equity） |
3,706,019,231.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,166,784,119.61 |
